Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Last trade$2.54
Day change-$0.06 (-2.31%)
Day range$2.53 – $2.64
Volume23,561
Market cap$2M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$2.14M
Price / earnings
—
Price / book
0.07×
Price / sales
0.06×
EV / sales
-0.35×
EV / EBITDA
2.64×
Profitability
Earnings per share
-$7.49
Return on assets
-18.23%
Return on equity
-21.56%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
6.47×
Quick ratio
4.03×
Cash ratio
3.05×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$6.04M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SBFM, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$9.44M
$9.26M
$8.09M
$8.58M
$9.42M
$9.41M
$8.9M
$9.59M
Cost of revenue
$6.34M
$6.84M
$5.91M
$5.55M
$6.34M
$5.99M
$6.17M
$6.5M
Gross profit
$3.1M
$2.43M
$2.18M
$3.03M
$3.07M
$3.42M
$2.73M
$3.09M
Selling, general and administrative
$3.14M
$3.16M
$3.11M
$3.98M
$2.92M
$3.23M
$3.24M
$4.15M
Research and development
$1.56K
$13.22K
$31.72K
$73.5K
$119.3K
$196.23K
$215.28K
$149.27K
Total operating expenses
$4.39M
$4.04M
$3.58M
$4.82M
$4.16M
$5.48M
$4.03M
$5.13M
Operating income
-$1.29M
-$1.61M
-$1.4M
-$1.79M
-$1.09M
-$2.05M
-$1.3M
-$2.04M
Interest expense
$0
$0
$0
$0
$0
$0
$0
-$8.53K
Income before taxes
-$1.29M
-$1.56M
-$1.24M
-$1.73M
-$1.02M
-$1.98M
-$1.22M
-$2.29M
Income taxes
-$63.54K
$0
$0
$408.37K
-$137.44K
-$209.17K
-$40.16K
-$128.74K
Net income
-$1.22M
-$1.56M
-$1.24M
-$2.14M
-$883.82K
-$1.77M
-$1.18M
-$2.16M
Net income attributable to common shareholders
-$1.22M
-$1.56M
-$1.24M
-$2.14M
-$883.82K
-$1.77M
-$1.18M
-$2.16M
EBITDA
-$827.36K
-$1.2M
-$1.23M
-$1.46M
-$243.04K
-$855.41K
-$1.2M
-$1.66M
Basic earnings per share
-$5.20
-$23.00
-$50.00
-$87.87
-$38.80
-$78.80
-$88.00
-$508.78
Diluted earnings per share
-$5.20
-$23.00
-$50.00
-$87.87
-$38.80
-$78.80
-$88.00
-$508.78
Recent news
Company coverage with links to the original publishers.
Sunshine Biopharma (NASDAQ:SBFM) shares fell 5.17% to $0.30 in after-hours trading following the announcement of a one-for-ten reverse stock split effective June 1, 2026. The reverse split was undertaken to regain compliance with Nasdaq's minimum bid price requirement. The stock has declined 77.99% over the past 12 months and currently has a market capitalization of approximately $5.18 million.
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 from $4.13 a year earlier.
Travelers shares dipped 8.1% to $205.03 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
INVO Bioscience, Inc. (NASDAQ: INVO) shares shot up 256% to $2.78 after the company reported a year-over-year increase in fourth-quarter revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024.
Edible Garden AG Incorporated (NASDAQ: EDBL) gained 112% to $9.73 after the company reported preliminary first quarter FY24 results.
Sintx Technologies, Inc. (NASDAQ: SINT) jumped 53% to $0.0350.
VIA optronics AG (NYSE: VIAO) shares gained 50.4% to $0.3924 after dipping over 15% on Tuesday.
AERWINS Technologies Inc. (NASDAQ: AWIN) jumped 42.2% to $4.70.
The Children's Place, Inc. (NASDAQ: PLCE) climbed 35.5% to $9.64 after the company announced it entered into a new financing agreement with Mithaq Capital.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained 32% to $5.38 after the company announced that it submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals and confirmed that its most recent proposal to acquire Vanda remains open for Vanda and its Board of Directors to consider.
EZGO Technologies Ltd. (NASDAQ: EZGO) gained 28% to $2.20. EZGO entered into a strategic cooperation framework agreement with Woteam to jointly explore the Southeast Asian Market.
CXApp Inc. (NASDAQ: CXAI) shares rose 25% to $4.89 after the company announced 24% ARR growth in 2023.
TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) rose 19.6% to $2.0461.
WiSA Technologies, Inc. (NASDAQ:
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ rose 0.24% to 15,903.38. The S&P 500 also rose, gaining, 0.40% to 5,071.74.
Check This Out: Alphabet, Toll Brothers And 2 Other Stocks Insiders Are Selling
Leading and Lagging Sectors
Materials shares rose by 1% on Wednesday.
In trading on Wednesday, real estate shares fell by 0.3%.
Top Headline
Abbott Laboratories (NYSE: ABT) reported better-than-expected earnings for its first quarter.
The company posted first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion. Abbott’s adjusted diluted earnings per share was 98 cents, beating the analyst estimates of 95 cents.
Equities Trading UP
INVO Bioscience, Inc. (NASDAQ: INVO) shares shot up 203% to $2.35 after the company reported a ...
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.
Net revenue (managed) of $42.5 billion (+8% Y/Y), beating the consensus of $41.8 billion. Excluding an item resulted in an increase of $550 million (after tax) to reported net income from $13.4 billion to $14.0 billion and an increase of $0.19 per share to reported EPS from $4.44 to $4.63. EPS was $4.44, beating the consensus of $4.15.
JPMorgan Chase shares dipped 5.1% to $185.49 on Friday.
Here are some other stocks moving in today's mid-day session.
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) jumped 143% to $1.0101 after the company announced the completed execution of its three pivotal registration/validation batches of PAX-101.
EZGO Technologies Ltd. (NASDAQ: EZGO) gained 83.3% to $2.86. EZGO entered into a $1.84 million procurement agreement for sale of security patrol robots and platform.
Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares jumped 58.8% to $3.6550 after dipping 29% on Thursday. Allarity Therapeutics filed prospectus supplement to increase offering price of common stock that may be offered from $1.4 million to $2.4 million.
Beneficient (NASDAQ: BENF) rose 45.5% to $0.1006 after dipping around 10% on Thursday.
NextPlat Corp (NASDAQ: NXPL) shares jumped 44% to $2.1799 after the company reported a year-over-year increase in FY23 consolidated revenue results. NextPlat announced a proposed business combination with Progressive Care Inc.
HUB Cyber Security Ltd. (NASDAQ: HUBC) gained 31.6% to $1.54.
9F Inc. (NASDAQ: JFU) surged 25.1% to $3.63.
Hanryu Holdings, Inc. (NASDAQ: HRYU) surged 25% to $0.51.
Argan, Inc. (NYSE: AGX) gained 21.5% to $59.97 as the company reported better-than-expected results for its fourth quarter on Thursday.
Rent the Runway, Inc. (NASDAQ: RENT) gained 19.6% to $23.55. Rent the Runway shares jumped 162% ...
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Friday.
The Dow traded down 0.82% to 38,143.73 while the NASDAQ fell 1.16% to 16,252.28. The S&P 500 also fell, dropping, 0.98% to 5,147.87.
Check This Out: Best Buy, Box And 2 Other Stocks Insiders Are Selling
Leading and Lagging Sectors
Energy shares rose by 0.9% on Friday.
In trading on Friday, information technology shares fell by 1.4%.
Top Headline
Wells Fargo & Company (NYSE: C) posted stronger-than-expected earnings for its first quarter.
Wells Fargo reported first-quarter earnings per share of $1.20, beating the analyst consensus of $1.09. Quarterly sales of $20.86 billion topped the Wall Street view of $20.20 billion.
Equities Trading UP
PaxMedica, Inc. (NASDAQ: PXMD) shares shot up 158% to $1.07 after the company announced the completed execution of three pivotal registration/validation batches of PAX-101.
Shares of EZGO Technologies Ltd. (NASDAQ: EZGO) got a boost, surging 90% to $2.9690. EZGO entered into a $1.84 million procurement agreement for sale of security patrol robots and platform.
NextPlat Corp (NASDAQ: NXPL) shares were also up, gaining 32% to $1.9987 after the company reported a year-over-year increase in FY23 consolidated revenue results. ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.